| scholarly article | Q13442814 |
| P50 | author | Wim Jennes | Q50998991 |
| Xaveer Van Ostade | Q50999001 | ||
| P2093 | author name string | Bea Vuylsteke | |
| Edmond Coen | |||
| Geert Van Raemdonck | |||
| Geert Zegels | |||
| P2860 | cites work | A functional and regulatory network associated with PIP expression in human breast cancer | Q21143857 |
| Human S100A12: a novel key player in inflammation? | Q24336365 | ||
| LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction | Q24675839 | ||
| The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection | Q24676095 | ||
| Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor | Q24676276 | ||
| Resistance to HIV Infection | Q27473466 | ||
| Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection | Q27485184 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement | Q28139286 | ||
| A statistical model for identifying proteins by tandem mass spectrometry | Q28186251 | ||
| HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes | Q28198109 | ||
| Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search | Q28211385 | ||
| Protein C inhibitor--a novel antimicrobial agent | Q28268083 | ||
| HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships | Q28731648 | ||
| Fate and distribution of seminal plasma proteins in the genital tract of the female rat after natural mating | Q73347972 | ||
| Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991-1998 | Q77536562 | ||
| Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells | Q79690127 | ||
| Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use | Q82803771 | ||
| Polymorphisms in the protein C inhibitor gene in in vitro fertilization failure | Q84573370 | ||
| Innate Molecular and Anatomic Mucosal Barriers against HIV Infection in the Genital Tract of HIV‐Exposed Seronegative Individuals | Q85120171 | ||
| Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry | Q29547311 | ||
| The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. | Q30360761 | ||
| Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form | Q33218414 | ||
| Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid | Q33227608 | ||
| Comparative study of [Three] LC-MALDI workflows for the analysis of complex proteomic samples | Q33228830 | ||
| Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. | Q33235253 | ||
| Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition | Q33474302 | ||
| Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies | Q33627673 | ||
| Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection | Q33808640 | ||
| Mucosal correlates of protection in HIV-1-exposed sero-negative persons | Q33911540 | ||
| Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication | Q33937364 | ||
| Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya | Q34395906 | ||
| Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract. | Q34467932 | ||
| Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells | Q34541093 | ||
| S100 proteins in the epidermis | Q34548562 | ||
| Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. | Q34707171 | ||
| Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals. | Q34754902 | ||
| Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples | Q34976381 | ||
| Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids | Q35075174 | ||
| Determinants of protection among HIV‐exposed seronegative persons: an overview | Q35252566 | ||
| Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. | Q35609521 | ||
| The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of Entry | Q35852782 | ||
| Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells | Q35868058 | ||
| Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals. | Q36415776 | ||
| Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands. | Q36595378 | ||
| Use of antiretrovirals for HIV prevention: what do we know and what don't we know? | Q36816377 | ||
| Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women | Q36863855 | ||
| Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense | Q37043675 | ||
| Vaginal microbicides and the prevention of HIV transmission | Q37063819 | ||
| Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse | Q37085424 | ||
| Vaginal drug delivery systems for HIV prevention | Q37149107 | ||
| The role of serpins in vertebrate immunity | Q37170955 | ||
| The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract | Q37210863 | ||
| Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies | Q37211585 | ||
| Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples | Q37237797 | ||
| The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis | Q37317127 | ||
| HIV infection of the genital mucosa in women. | Q37370910 | ||
| The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer | Q37487325 | ||
| Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. | Q37581432 | ||
| S100A6 - new facts and features | Q37627980 | ||
| Systems biology-based approaches to understand HIV-exposed uninfected women. | Q37738711 | ||
| Historical perspective on HIV‐exposed seronegative individuals: has nature done the experiment for us? | Q37795829 | ||
| Cohorts for the study of HIV‐1-exposed but uninfected individuals: benefits and limitations | Q37795831 | ||
| Defining the genital immune correlates of protection against HIV acquisition: co-infections and other potential confounders. | Q37828017 | ||
| Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). | Q37854081 | ||
| Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? | Q37878658 | ||
| Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda | Q38885289 | ||
| Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract | Q39022486 | ||
| HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire | Q39104495 | ||
| Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Côte d'Ivoire | Q39104499 | ||
| Altered dendritic cell-natural killer interaction in Kenyan sex workers resistant to HIV-1 infection | Q39677067 | ||
| IgM antibodies directed to HIV: the neglected issue? | Q40626586 | ||
| Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. | Q40762424 | ||
| The tat protein of HIV-1 induces galectin-3 expression | Q40965617 | ||
| HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations. | Q42785384 | ||
| Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers | Q43481738 | ||
| Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort | Q43485209 | ||
| Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells | Q43807143 | ||
| Monocyte activation by circulating fibronectin fragments in HIV-1-infected patients | Q44987510 | ||
| Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission | Q45738773 | ||
| Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women | Q45740268 | ||
| Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group | Q45752474 | ||
| HIV-1 antibody serum negativity with vaginal secretions positivity | Q46254997 | ||
| Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers | Q46625718 | ||
| Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders | Q46689948 | ||
| Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire | Q46741182 | ||
| Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. | Q51405927 | ||
| A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers | Q57766050 | ||
| A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection | Q57997363 | ||
| The ‘immunologic advantage’ of HIV-exposed seronegative individuals | Q57997441 | ||
| Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate | Q57997600 | ||
| HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals | Q57997711 | ||
| Dinucleotide repeat polymorphism at the human protein C inhibitor (PCI) locus | Q72250088 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11-21 | |
| P577 | publication date | 2014-05-05 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Increased Serpin A5 levels in the cervicovaginal fluid of HIV-1 exposed seronegatives suggest that a subtle balance between serine proteases and their inhibitors may determine susceptibility to HIV-1 infection | |
| P478 | volume | 458-459 |
| Q90028613 | A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection |
| Q41832554 | A Quantitative Proteomics Approach to Clinical Research with Non-Traditional Samples |
| Q47397671 | Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer. |
| Q90149711 | Comparative transcriptome analysis of the human endocervix and ectocervix during the proliferative and secretory phases of the menstrual cycle |
| Q47630183 | Discovery of Antimicrobial Peptides in Cervical-Vaginal Fluid from Healthy Nonpregnant Women via an Integrated Proteome and Peptidome Analysis |
| Q33703750 | Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers |
| Q26853681 | Proteomics, biomarkers, and HIV-1: A current perspective |
| Q33633451 | Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders |
| Q36939732 | Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation |
| Q37342332 | Urinary proteomic pattern in female stress urinary incontinence: a pilot study. |
Search more.